CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota. Show more
Location: 9201 West Broadway Avenue, Minneapolis, MN, 55445, United States | Website: https://www.cvrx.com | Industry: Medical Devices | Sector: Healthcare
Market Cap
258.2M
52 Wk Range
$4.30 - $18.55
Previous Close
$8.80
Open
$8.73
Volume
323,469
Day Range
$8.37 - $10.00
Enterprise Value
223.6M
Cash
85.12M
Avg Qtr Burn
-9.605M
Insider Ownership
4.30%
Institutional Own.
65.03%
Qtr Updated
09/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
